Strategic alliance between the infectious diseases specialist and intensive care unit physician for change in antibiotic use

Journal of Chemotherapy

Volumn 17, Issue 1, 2005, Pages 74-76

  Curcio, D ^a,b,c   Belloni, R ^a  

^a Sanatorio Guemes   (Argentina)

^b Capital Federal   (Argentina)

^c NONE   (Argentina)

Author keywords

Antibiotic usage; Intensive care unit; Leadership

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; COST CONTROL; DRUG COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDICAL SPECIALIST; MORTALITY; PHYSICIAN; PRESCRIPTION;

EID: 16244422347     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.1.74     Document Type: Article

References (12)

1. Yinnon AM. Whither infectious diseases consultations? Analysis of 14,500 consultations from 5-year period. Clin Infect Dis 2001;33:1661-7.
2. John JF Jr, Fishman NO. Programmatic role of infectious diseases physician in controlling antimicrobial cost in the hospital. Clin Infect Dis 1997; 24:471-85.
3. Jasovich A, Curcio D, Caso Nunez H, et al. Impact of the infectious disease team on the rationale for antibiotic usage: an expeditious intervention strategy which avoids limiting the physician's freedom. J Chemother 2003; 15(4):409-11.
4. Lo E, Rezai K, Evans AT, et al. Why don't they listen? Adherence to recommendations of Infectious Disease Consultations. Clin Infect Dis 2004; 38:1212-1218.
5. Maxwell M, Heaney D, Howie JG, Noble S. General practice fund holding: observations on prescribing patterns and costs using the defined daily dose method. Br Med J 1993; 307(6913):1190-4.
6. Fox BC, Imrey PB, Voigths MB, Norwood S. Infectious diseases consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study. Clin Infect Dis 2001;33:1981-9.
7. Marschner JP, Thurmann P, Harder S, Rietbrock N. Drug utilization review in a surgical intensive care unit. J Hosp Infect 1994;8:159-67.
8. Sintchenko V, Iredell JR, Gilbert GL, Coiera E. What do physicians think about evidence-based antibiotic use in critical care? A survey of Australian intensives and infectious disease practitioners. Intern Med J 2001; 31(8):462-9.
9. Kollef MH, Vlasnik J, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 2000; 28:3456-64.
10. Quale J, Landman D, Saurina G, Atwood E, Di Tore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23(5):1020-5.
11. Waterer G, Wunderink, R. Increasing threat of Gram-negative bacteria. Crit Care Med 2001; 29(4):N75-N81.
12. Greco PJ, Eisenberg JM. Changing physician's practices. N Eng J Med 1993;(329)17:12714.